PharmAthene Inc (NYSE MKT LLC:PIP)

1.67
Delayed Data
As of 4:01pm ET
 +0.02 / +1.21%
Today’s Change
1.19
Today|||52-Week Range
2.59
-7.73%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$105.3M

Company Description

PharmAthene, Inc. operates as a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its biodefense candidates include Anthrax vaccines including SparVax, a second generation liquid recombinant protective antigen, anthrax vaccine and a next generation lyophilized anthrax vaccine containing rPA; recombinant butyrylcholinesteras bioscavenger, a medical counter measure for nerve agent poisoning by organ phosphorous compounds, including nerve gases and pesticides; and valortim, a fully human monoclonal antibody for the prevention and treatment of anthrax infection. The company was founded in March 2001 and is headquartered in Annapolis, MD.

Contact Information

PharmAthene, Inc.
1 Park Place
Annapolis Maryland 21401
P:(410) 269-2600
Investor Relations:

Employees

Shareholders

Individual stakeholders36.32%
Mutual fund holders3.64%
Other institutional27.52%

Top Executives

John M. GillPresident, Chief Executive Officer & Director
Jeffrey Michael JonesChief Operating Officer & Vice President
Philip MacNeillCFO, Secretary, Treasurer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account